GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Oncology/CT Use and Future Cancer Risk

CT Use and Future Cancer Risk

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated August 1, 2025

Quick Answer

The rising use of CT (computed tomography) scans has sparked concerns about its potential long-term impact on cancer risk, as highlighted by a recent modeling study. Below is a detailed analysis of the findings and their implications: ### Key Findings: 1.


The rising use of CT (computed tomography) scans has sparked concerns about its potential long-term impact on cancer risk, as highlighted by a recent modeling study. Below is a detailed analysis of the findings and their implications:

### Key Findings:

1. **CT Scan Usage in 2023**:

  • In the U.S., approximately **62 million patients** underwent nearly **93 million CT scans** in 2023 alone.
  • This marks a significant reliance on CT imaging for diagnostic and medical purposes.

2. **Projected Cancer Cases**:

  • Researchers estimate that the radiation exposure from this level of CT use could result in about **103,000 future cancer cases**.
  • These cases could account for up to **5% of all annual cancer diagnoses**, a figure comparable to cancer risks associated with **alcohol consumption** or **excess body weight**.

3. **Age and Type of CT Scans**:

  • **Adults**: Abdomen and pelvis CT scans contributed the most to the projected cancer cases.
  • **Children**: Head CT scans were the largest contributor to projected cancers in this group.
  • **Highest Risk Per Scan**: Children under **1 year of age** face the highest risk per individual scan due to their greater sensitivity to radiation.
  • **Largest Number of Cases Overall**: Older adults had the highest number of projected cancer cases, primarily because they undergo CT scans more frequently.

4. **Cancer Types Linked to CT Radiation**:

  • **Adults**: Lung, colon, bladder cancers, and leukemia were the most commonly linked cancers.
  • **Children**: Thyroid, lung, and breast cancers were the most frequently associated with CT scan radiation.

5. **Lifetime Risk Increase**:

  • The overall lifetime risk of developing cancer increases slightly due to CT scan radiation exposure — from about **50% to 52.5%**.

### Implications:

  • **Balancing Risks and Benefits**:
  • While there is a small increase in lifetime cancer risk, experts emphasize that CT scans are often **essential and life-saving** tools in medical diagnosis and treatment.
  • The **diagnostic benefits** of CT imaging generally outweigh the **small added cancer risk**, especially in urgent or critical cases.
  • **Recommendations for Safer Use**:
  • **Reducing Unnecessary Imaging**: Avoiding CT scans that are not medically necessary can help lower overall radiation exposure.
  • **Minimizing Radiation Dose**: Using the **lowest radiation dose possible** for effective imaging can reduce long-term risks.
  • **Special Considerations for Children**: Pediatric patients, especially infants, should be given extra care in minimizing radiation exposure due to their higher sensitivity.

### Conclusion:

CT scans are indispensable tools in modern medicine, but their increasing use raises valid concerns about long-term cancer risks. The study underscores the need for judicious use of CT imaging, particularly in vulnerable populations such as children and frequent users like older adults. By optimizing scanning practices and reducing unnecessary exposure, healthcare providers can continue to maximize the diagnostic benefits of CT scans while minimizing potential risks.

Related Q&A

The First Standardized PET Response Framework for Neuroendocrine Tumors: The Lancet Oncology | July 2026

Introduction: Somatostatin receptor (SSTR) PET/CT has become indispensable for diagnosing, staging, and monitoring neuroendocrine tumors (NETs). However, until now, there has been no standardized method for assessing treatment response using SSTR PET imaging. This international...

Staging Laparoscopy in Gastric Cancer: Annals of Surgical Oncology | July 2026

Introduction: Staging laparoscopy (SL) is recommended for patients with locally advanced gastric cancer to detect occult peritoneal metastases before curative treatment. However, its real-world utilization across Europe remains uncertain. This large GASTRODATA study evaluated the...

Celecoxib Boosts Neoadjuvant Immunotherapy in dMMR/MSI-H CRC : Lancet Oncol | Jul 2026

Introduction: Neoadjuvant immune checkpoint inhibitors have transformed the management of mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H) locally advanced colorectal cancer, achieving unprecedented pathological response rates. Experimental evidence suggests that cyclooxygenase-2 (COX-2) inhibition may enhance...

Cancer Cachexia: Science | July 2026

Introduction: Cancer-associated cachexia is a devastating syndrome characterized by loss of appetite, weight loss, and muscle wasting, affecting up to half of patients with lung cancer. This landmark study uncovers a previously unrecognized mechanism linking...

Liquid Biopsy-Guided Cetuximab Rechallenge in mCRC: ESMO GI Cancers Congress | July 2026

Introduction: Resistance to anti-EGFR therapy has traditionally been considered irreversible in metastatic colorectal cancer (mCRC). However, emerging evidence suggests that resistance is dynamic and can be monitored using circulating tumor DNA (ctDNA). The CAPRI-2 trial...

PD-(L)1 Inhibitors Plus Chemotherapy in Advanced Gastric Cancer: CGH | July 2026

Introduction: Immune checkpoint inhibitors combined with chemotherapy have become the standard first-line treatment for advanced HER2-negative gastric and gastroesophageal junction cancers. This meta-analysis evaluated whether treatment benefits differ between Asian and non-Asian populations. Why was...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer